A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
Clinical trial NCT07754825 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07754825
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.